LLY

864.79

-0.45%↓

UNH

533.89

+0.16%↑

JNJ

155.91

+1.11%↑

ABBV

191.68

+0.7%↑

NVO

83.77

-0.19%↓

LLY

864.79

-0.45%↓

UNH

533.89

+0.16%↑

JNJ

155.91

+1.11%↑

ABBV

191.68

+0.7%↑

NVO

83.77

-0.19%↓

LLY

864.79

-0.45%↓

UNH

533.89

+0.16%↑

JNJ

155.91

+1.11%↑

ABBV

191.68

+0.7%↑

NVO

83.77

-0.19%↓

LLY

864.79

-0.45%↓

UNH

533.89

+0.16%↑

JNJ

155.91

+1.11%↑

ABBV

191.68

+0.7%↑

NVO

83.77

-0.19%↓

LLY

864.79

-0.45%↓

UNH

533.89

+0.16%↑

JNJ

155.91

+1.11%↑

ABBV

191.68

+0.7%↑

NVO

83.77

-0.19%↓

Search

Adaptive Biotechnologies Corp

Closed

7.78 1.83

Overview

Share price change

24h

Current

Min

7.41

Max

7.89

Recommendations

By TipRanks

Recommendations

Buy

12 Months Forecast

+5.21 upside

Dividends

By Dow Jones

Next Earnings

6 May 2025

Technical Score

By Trading Central

Confidence

Weak Bearish Evidence

Adaptive Biotechnologies Corp Chart

Past performance is not a reliable indicator of future results.

Related News

11 Feb 2025, 22:37 UTC

Earnings

America Movil 4Q Profit Falls on Exchange Losses

11 Feb 2025, 21:33 UTC

Earnings

Commonwealth Bank Raises 1st Half Profit 6.1% Amid Higher Volumes -- Update

11 Feb 2025, 23:49 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

11 Feb 2025, 23:49 UTC

Market Talk

Nikkei May Rise as Weak Yen Raises Hopes for Earnings Growth -- Market Talk

11 Feb 2025, 23:37 UTC

Market Talk
Earnings

Suncorp's 1H Earnings Beat Power Shares Higher -- Market Talk

11 Feb 2025, 23:36 UTC

Market Talk

Gold Edges Higher Amid Mixed Signals -- Market Talk

11 Feb 2025, 23:01 UTC

Market Talk

Commonwealth Bank Bear Says Results Don't Justify Share Price -- Market Talk

11 Feb 2025, 22:55 UTC

Earnings

Samsung Fire & Marine Insurance Co. Ltd. 4Q Consolidated Rev KRW6.297T Vs KRW5.114T

11 Feb 2025, 22:55 UTC

Earnings

Table: Samsung Fire & Marine 4Q Consolidated Net KRW207.88B Vs KRW178.35B

11 Feb 2025, 22:55 UTC

Earnings

Samsung Fire & Marine Insurance Co. Ltd. 4Q Consolidated Op Pft KRW252.81B Vs Op KRW206.21B

11 Feb 2025, 22:55 UTC

Earnings

Samsung Fire & Marine Insurance Co. Ltd. 4Q Consolidated Net KRW207.88B Vs KRW178.35B

11 Feb 2025, 22:33 UTC

Top News

The Switcheroo That Let Kanye West Advertise Swastika Shirts During the Super Bowl -- WSJ

11 Feb 2025, 22:30 UTC

Market Talk

Flu Vaccines Proving Problematic for CSL -- Market Talk

11 Feb 2025, 22:13 UTC

Market Talk
Earnings

Covid Roundup: Market Talk

11 Feb 2025, 22:13 UTC

Market Talk
Earnings

Gilead's HIV Segment Buoying Product Sales Amid Covid Losses -- Market Talk

11 Feb 2025, 22:04 UTC

Earnings

Intact Financial Raises Dividend to C$1.33 >IFC.T

11 Feb 2025, 22:01 UTC

Earnings

Intact Financial 4Q EPS C$3.58 >IFC.T

11 Feb 2025, 21:50 UTC

Market Talk
Acquisitions, Mergers, Takeovers

Financial Services Roundup: Market Talk

11 Feb 2025, 21:50 UTC

Market Talk

Basic Materials Roundup: Market Talk

11 Feb 2025, 21:50 UTC

Market Talk
Acquisitions, Mergers, Takeovers

Health Care Roundup: Market Talk

11 Feb 2025, 21:44 UTC

Earnings

America Movil 4Q EBITDA MXN91.11B, Up 16% on Year >AMX.MX

11 Feb 2025, 21:43 UTC

Earnings

America Movil 4Q Rev MXN236.94B, Up 18% on Year >AMX.MX

11 Feb 2025, 21:41 UTC

Earnings

America Movil 4Q Net MXN9.48B Vs. Net MXN18.06B >AMX.MX

11 Feb 2025, 21:37 UTC

Earnings

Zillow Beat Earnings Expectations. The Stock Fell. -- Barrons.com

11 Feb 2025, 21:36 UTC

Earnings

Evolution 1H Operating Mine Cash Flow A$991 Million, Up 60% On-Year

11 Feb 2025, 21:36 UTC

Earnings

Evolution 1H Underlying Ebitda A$1.01 Billion, Up 77% On-Year

11 Feb 2025, 21:35 UTC

Earnings

Evolution 1H Gearing 23% Vs 30% Year Prior

11 Feb 2025, 21:34 UTC

Earnings

Evolution: Mungari Project Tracking 6% Below Budget, at A$235 Million

11 Feb 2025, 21:34 UTC

Earnings

Evolution Revises Capex Guidance to Reflect Early Completion of Mungari Plant Expansion

11 Feb 2025, 21:33 UTC

Earnings

Evolution Reiterates FY25 Production, Cost Guidance

Peer Comparison

Price change

Adaptive Biotechnologies Corp Forecast

Price Target

By TipRanks

5.21% upside

12 Months Forecast

Average 8.08 USD  5.21%

High 10 USD

Low 7 USD

Based on 6 Wall Street analysts offering 12 month price targets forAdaptive Biotechnologies Corp - Dist in the last 3 months.

Rating Consensus

By TipRanks

Buy

6 ratings

4

Buy

2

Hold

0

Sell

Technical Score

By Trading Central

7.38 / 7.85Support & Resistance

Short Term

Weak Bearish Evidence

Intermediate Term

Bullish Evidence

Long Term

Weak Bullish Evidence

Financials

$

About Adaptive Biotechnologies Corp

Adaptive Biotechnologies Corporation, a commercial-stage company, develops an immune medicine platform for the diagnosis and treatment of various diseases. The company offers immunosequencing platform which combines a suite of proprietary chemistry, computational biology, and machine learning to generate clinical immunomics data to decode the adaptive immune system. It also provides clonoSEQ diagnostic test which detects and monitors the remaining number of cancer cells that are present in a patient's body during and after treatment, known as Minimal Residual Disease (MRD). The company offers products and services for life sciences research, clinical diagnostics, and drug discovery applications. Adaptive Biotechnologies Corporation has strategic collaborations with Genentech, Inc. for the development, manufacture, and commercialization of neoantigen directed T cell therapies for the treatment of a range of cancers; and Microsoft Corporation to develop diagnostic tests for the early detection of various diseases from a single blood test. The company was formerly known as Adaptive TCR Corporation and changed its name to Adaptive Biotechnologies Corporation in December 2011. Adaptive Biotechnologies Corporation was incorporated in 2009 and is headquartered in Seattle, Washington.